title: Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select.
authors.affiliation: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and The James Buchanan Brady Urological Institute, Baltimore, MD cdrake@jhmi.edu.
authors.forename: Charles G
authors.initials: CG
authors.lastname: Drake
authors.affiliation: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and The James Buchanan Brady Urological Institute, Baltimore, MD.
authors.forename: Trinity J
authors.initials: TJ
authors.lastname: Bivalacqua
authors.affiliation: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and The James Buchanan Brady Urological Institute, Baltimore, MD.
authors.forename: Noah M
authors.initials: NM
authors.lastname: Hahn
mesh_terms: D060890:B7-H1 Antigen; D002295:Carcinoma, Transitional Cell; D016923:Cell Death; D006801:Humans; D001749:Urinary Bladder Neoplasms; D014571:Urologic Neoplasms
chemical_list: D060890:B7-H1 Antigen